Long-term treatment of α1-antitrypsin deficiency-related pulmonary emphysema with human α1-antitrypsin;Langzeittherapie des α1-Antitrypsin-Mangelassoziierten Lungenemphysems mit Humanem α1-Antitrypsin

Pneumologie

Volumn 52, Issue 10, 1998, Pages 545-552

  Wencker, Marion ^a   Banik, N ^b   Buhl, R ^c   Seidel, Regina ^b   Konietzko, N ^a  

^a RUHRLANDKLINIK   (Germany)

^b BAYER AG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEUKOCYTE ELASTASE;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; DRUG EFFECT; FEASIBILITY STUDY; GENETICS; LONG TERM CARE; MIDDLE AGED; PHENOTYPE;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFUSIONS, INTRAVENOUS; LONG-TERM CARE; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY EMPHYSEMA; TREATMENT OUTCOME;

EID: 0031593555     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 112 (1997) 607-613
2. Barker, A. F., F. Siemsen, D. Pasley, R. D'Silva, A. S. Buist: Replacement therapy for hereditary alpha1-antitrypsin deficiency: A program for long-term administration. Chest 105 (1994) 1406-1410
3. Bergin C., N. Müller, D. M. Nichols, G. Lillington, J. C. Hogg, B. Mullen, M. R. Grymaloski, S. Osborne, P. D. Pare : The diagnosis of emphysema: A computed tomographic-pathologic correlation. Am. Rev. Respir. Dis. 133 (1986) 541-546
4. Brantly, M. L., L. D. Paul, B. H. Miller, R. T. Falk, M. Wu, R. G. Crystal: Clinical features and history of the destructive lung disease associated with Alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am. Rev. Respir. Dis. 138 (1988) 327-
5. 1-antitrypsin phenotypes. Chest 100 (1991) 703-708
6. Buist, A. S., B. Burrows, S. Eriksson, C. Mittman, M. Wu: The natural history of air-flow obstruction in PiZ Emphysema: Report of an NHLBI workshop. Am. Rev. Respir. Dis. 127 (Suppl) (1983) S43-S45
7. Burrows, B.: A clinical trial of efficacy of antiproteolytic therapy: can it be done? Am. Rev. Respir. Dis. 127 (1983) S42-S43
8. Cammarata, S. K., C. L. Stone, J. L. Carey, M. S. Eichenhorn: Failure to achieve adequate serum levels with monthly replacement therapy in alpha 1-antitrypsin deficiency. Chest 106 (1994) 651 -652
9. Cotes, J. E.: Lung function, Blackwell, Oxford 1979
10. 1-antitrypsin deficiency. Acta Med. Scand. 44 (Suppl.432) (1965) 1-85
11. Gadek, J. E., R. G. Crystal: Experience with replacement therapy in the destructive lung disease associated with severe alpha-1-antitrypsin deficiency. Am. Rev. Respir. Dis. 127 (1983) S45-S46
12. Gadek, J. E., H. Klein, P. V. Holland, R. G. Crystal: Replacement therapy of alpha 1-antitrypsin deficiency: reversal of protease-antiprotease imbalance within the alveolar structures of PiZZ subjects. J. Clin. Invest. 68 (1981) 1158-1165
13. Gadek, J. E., R. L. Zimmerman, G. A. Fells, S. I. Rennard, R. G. Crystal: Antielastases of the human alveolar structures: implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. 68 (1981) 889-898
14. 1-antitrypsin deficiency. JAMA 260 (1988) 1259-1264
15. Hutchison, D. C. S.: Natural history of alpha-1-protease inhibitor deficiency. Am. J. Med. 84 (Suppl 6A) (1988) 3-12
16. Hutchison, D. C. S., M. D. Hughes: Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved? Eur. Respir. J. (1997) 2191-2193
17. Jeppsson, J. O., B. Franzén: Typing of genetic variants of al-antitrypsin by electrofocussing. Clin. Chem. 28 (1982) 219-225
18. Konietzko, N., V. Schulz, G. Eckert: Die Progredienz des Lungenemphysems bei schwerem Alpha1-Pi Mangel - Eine retrospektive, mulitzentrische Studie der "Wissenschaftlichen Arbeitsgemeinschaft für die Therapie von Lungenerkrankungen eV (WATL)". Med. Klinik. 83 (1988) 1-6
19. Laird, N. M. J. H. Ware: Random-effects models for longitudinal data. Biometrics 38 (1982) 964-974
20. 1-antitrypsin deficiency. Am. J. Hum. Genet. 27 (1975) 213-217
21. Quanjer, P. H.: Standardized lung function testing. Eur. Respir. J. 6 (Suppl 6) (1993) 3-102
22. Schmidt, E. W., B. Rasche, W. T. Ulmer, N. Konietzko, M. Becker, J. P. Fallise, J. Lorenz, R. Ferlinz: Replacement therapy for alpha-1-protease inhibitor deficiency in Pi Z subjects with chronic obstructive lung disease. Am. J. Med. 84(Suppl 6A) (1988) 63-69
23. Seersholm, N., A. Kok-Jensen, A. Dirksen: Decline in FEV1 among patients with severe hereditary ctl-antitrypsin deficiency type PiZ. Am. J. Respir. Crit. Care Med. 152 (1995) 1922-1925
24. 1-antitrypsin deficiency? Eur. Respir. J. 10 (1997) 2260-2263
25. Viskum, K., A. Kok-Jensen: Criteria for alpha 1-antitrypsin substitution. Lung 168 Suppl (1990) 586-591
26. Wencker, M., M. Beume, C. Weisswange, N. Konietzko: Two year follow up of mean attenuation values by computed tomography in patients with Alpha-1-protease inhibitor deficiency. Am. J. Respir. Crit. Care Med. 149 (1994) A282 (Abstract)
27. Wencker, M., J. Denker, N. Konietzko: Serial measurements of FEV1 over 12 years in a patient with alpha-1-protease inhibitor deficiency: Influence of augmentation therapy and infections. Respiration 61 (1994) 195-198
28. Wewers, M. D., M. A. Casolaro, S. E. Sellers, S. C. Swayze, K. M. McPhaul, R. G. Crystal: Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N. Engl. J. Med. 316 (1987) 1055-1062
29. Wu, M. C., S. Eriksson: Lung function, smoking and survival in severe alpha-1-antitrypsin deficiency PiZZ. J. Clin. Epidem. 41 (1988) 1157-1165